Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer

Cancer Lett. 2022 Mar 31:529:168-179. doi: 10.1016/j.canlet.2022.01.005. Epub 2022 Jan 7.

Abstract

Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 2 (TIE2)-expressing macrophages (TEMs) are an angiogenesis-promoting subset of tumor-associated macrophages that have been demonstrated to be increased in solid tumors and associated with the progression of cervical cancer. However, the induction mechanism of TEMs remains unclear. Here, based on multicolor immunofluorescence of 58 cervical cancer tissues and the GEPIA database, we found that TEMs were increased in TIE2-high cervical cancer and related to shorter survival. In vitro and in vivo experiments verified that exosomes derived from TIE2-high cervical cancer cells transferred TIE2 protein directly to macrophages, thereby inducing TEMs. Similar to primary TEMs, TEMs induced by tumor-derived exosomes promoted angiogenesis, could be induced by angiopoietin-2, and possessed an M2-like phenotype. In conclusion, exosomes derived from TIE2-high cervical cancer cells induce TEMs by directly transporting TIE2 to promote tumor angiogenesis.

Keywords: Cervical carcinoma; Extracellular vesicles; TIE2-expressing macrophages; Tumor microenvironment; Tumor-associated macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Animals
  • Cell Line, Tumor
  • Disease Models, Animal
  • Exosomes / metabolism*
  • Female
  • Humans
  • Immunohistochemistry
  • Immunophenotyping
  • Macrophages / metabolism*
  • Mice
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Neovascularization, Pathologic / metabolism*
  • Prognosis
  • Protein Transport
  • Receptor, TIE-2 / metabolism*
  • Transcriptome
  • Tumor Microenvironment
  • Tumor-Associated Macrophages / immunology
  • Tumor-Associated Macrophages / metabolism
  • Tumor-Associated Macrophages / pathology
  • Uterine Cervical Neoplasms / etiology
  • Uterine Cervical Neoplasms / metabolism*
  • Uterine Cervical Neoplasms / pathology*
  • Xenograft Model Antitumor Assays

Substances

  • Receptor, TIE-2